As a follow up to completing patient enrollment and sample collection in connection with its Phase II pilot study, John Cousins, President and CEO of Biomoda, Inc. (OTCBB: BMOD), is presenting its proprietary CyPath® diagnostic assay for the detection of early-stage cancers at OneMedPlace’s mid-year finance forum in New York on Wednesday, June 30, 2010. Cousins’ presentation will be Webcast at approximately 3:20pm Eastern Daylight Time on Wednesday, June 30th, and can be viewed live online by clicking here.
Advertisement
